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HDAC3 is a molecular brake of the metabolic
switch supporting white adipose tissue browning
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Emma De Fabiani1, Scott W. Hiebert4 & Maurizio Crestani 1
White adipose tissue (WAT) can undergo a phenotypic switch, known as browning, in
response to environmental stimuli such as cold. Post-translational modiﬁcations of histones
have been shown to regulate cellular energy metabolism, but their role in white adipose
tissue physiology remains incompletely understood. Here we show that histone deacetylase 3
(HDAC3) regulates WAT metabolism and function. Selective ablation of Hdac3 in fat
switches the metabolic signature of WAT by activating a futile cycle of de novo fatty acid
synthesis and β-oxidation that potentiates WAT oxidative capacity and ultimately supports
browning. Speciﬁc ablation of Hdac3 in adipose tissue increases acetylation of enhancers in
Pparg and Ucp1 genes, and of putative regulatory regions of the Ppara gene. Our results unveil
HDAC3 as a regulator of WAT physiology, which acts as a molecular brake that inhibits fatty
acid metabolism and WAT browning.
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White (WAT) and brown (BAT) adipose tissues differ intheir morphology and functionality and are marked bydistinct metabolic signatures. However, upon speciﬁc
environmental cues (for example, cold exposure), WAT switches
to a brown like-phenotype in a phenomenon called browning1–3.
The identiﬁcation of factors that may contribute to control
browning is still a matter of intense investigations. Several studies
demonstrated that HDACs participate in metabolic regulation of
different organs, especially highlighting a pivotal role played by
histone deacetylase 3 (HDAC3) as modulator of metabolic
reprogramming in liver4, 5 and heart6, 7. Our previous studies
demonstrated that chemical inhibition of class I HDACs with
MS-275 ameliorates obesity and glucose tolerance in db/db and
diet-induced obese mice, by reshaping adipose tissue metabolism
and via induction of WAT browning8, 9. In this regard, it has
been shown that HDAC1 and HDAC2 play a role in adipose
tissue physiology10; furthermore, genetic ablation in adipose
tissue of NCoR111, a co-repressor interacting with HDAC3,
improved adipose tissue functionality, and insulin resistance12.
Several groups reported evidences about a link
between metabolism and post-translational modiﬁcations of
chromatin4, 5, 13–16, sparking new interest in the role of
epigenome modiﬁers in determining the metabolic signature of
speciﬁc tissues. However, the links between metabolic phenotype
and chromatin modiﬁcations (for example, histone acetylation),
and the underlying regulators of the epigenome dynamics in
adipose tissue have started to emerge only recently.
By using a combination of transcriptomic, metabolomic,
and proteomic approaches coupled with genetic manipulation
of mouse and cellular models, we show that HDAC3 regulates
the metabolic phenotype of WAT by acting as a molecular
brake of the cellular metabolic rewiring that sustains WAT
browning.
Results
Differential expression of metabolic genes in BAT vs. WAT. To
characterize the phenotype of fat speciﬁc Hdac3 KO mice, we ﬁrst
veriﬁed that ﬂoxed mice, here used as controls for comparison vs.
H3atKO mice, display the typical molecular signature underlying
the distinct morphological and functional features of WAT and
BAT. To this end, we conducted a focused gene expression
proﬁling of inguinal WAT (IngWAT) and BAT in ﬂoxed
C57Bl/6J mice. As expected, this analysis showed that BAT is
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Fig. 1 Adipose ablation of Hdac3 results in browning of WAT in mice on LFD. a Gene expression analysis of BAT markers and of genes involved in glucose
and lipid metabolism in brown and inguinal white adipose tissues (IngWAT) (n= 11); b Western blot analysis of HDAC3, showing the deletion of the
protein in IngWAT of Hdac3 knock out (H3atKO) mice vs. ﬂoxed mice (n= 3); c Representative image of IngWAT from ﬂoxed and H3atKO mice;
d Hematoxylin–eosin staining of IngWAT from ﬂoxed and H3atKO mice, scale bar is 100 μm.; e, f Quantiﬁcation of multilocular adipocytes and adipocyte
size (n= 3 per group); g Immunohistochemical analysis of UCP1 IngWAT of ﬂoxed and H3atKO mice; h Body temperature of ﬂoxed and H3atKO mice
exposed to 4 °C for 24 h (n= 6 per group). Data are presented as mean± s.e.m. Statistical analysis: Student’s t-test, *p< 0.05, **p< 0.01, and ***p< 0.001
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characterized by remarkably high mRNA levels of brown fat
speciﬁc genes such as those encoding for uncoupling protein 1
(Ucp1), β3-adrenergic receptor (Adrb3), deiodinase 2 (Dio2),
vascular endothelial growth factor 2a (Vegfa2), PR domain con-
taining 16 (Prdm16) and peroxisome proliferator-activated
receptor α (Ppara) (Fig. 1a). However, this comparison revealed
that BAT also showed exceptional upregulation of several genes
involved in lipid, glucose, and citrate metabolism (Fig. 1a),
highlighting brown fat as an organ with “high metabolic rate”,
with a concurrent activation of lipolytic/fatty acid (FA) β-oxida-
tion and lipogenic gene programs in BAT, to meet the energy
needs related to thermogenic function17–19. Overall, the
comparative analysis of gene expression conﬁrmed the
differential metabolic signature of brown vs. WAT in this strain
of mice. We thus used the fat speciﬁc Hdac3 KO mouse model to
investigate the role of HDAC3 in the differential metabolic
phenotype of brown vs. WATs. The transcriptional analysis
of Hdac3 mRNA revealed a threefold higher expression in BAT as
compared to IngWAT, in ﬂoxed control mice (Supplementary
Fig. 1a).
Adipose ablation of HDAC3 induces browning of white fat.
Several studies demonstrated that HDACs participate in
metabolic regulation of different organs4–7. We previously
showed that chemical class I HDAC inhibitor MS-275 improves
obesity and glucose tolerance in db/db and diet-induced obese
mice, via induction of WAT browning8, 9. Since it has been
demonstrated that genetic ablation of NCoR1 in adipose tissue11,
a co-repressor interacting with HDAC3, improved adipose tissue
functionality and insulin resistance12, we decided to investigate
the role of HDAC3 in adipose tissue physiology and metabolism.
To this end, we deleted Hdac3 in adipose tissues by breeding
Hdac3 ﬂoxed mice with mice expressing the Cre recombinase
under the control of the adiponectin gene promoter (Adipoq).
Selective deletion of Hdac3 in adipose tissues (H3atKO) was
conﬁrmed by PCR and western blot (Fig. 1b, Supplementary
Fig. 1b, Supplementary Fig. 2a, b, Supplementary Fig. 3a, b).
Interestingly, we observed that, despite no differences in total
body weight gain (Supplementary Fig. 1c), H3atKO mice showed
reduction of epididymal WAT (EpiWAT; Supplementary Fig. 2c),
accompanied by a mild, though not statistically signiﬁcant,
reduction of IngWAT (Supplementary Fig. 1d). Surprisingly,
IngWAT appeared reddish (Fig. 1c) and hematoxylin/eosin
staining showed a clear difference of cellular morphology,
characterized by smaller, though not statistically signiﬁcant, cell
size and by the presence of multilocular adipocytes (Fig. 1d–f).
The immunohistochemical analysis of IngWAT revealed strong
increase of UCP1 staining (Fig. 1g). Most importantly, when
exposed to cold H3atKO mice were able to maintain body
temperature to values higher than those of ﬂoxed mice (Fig. 1h),
thus suggesting browning of WAT in H3atKO mice, which would
Ucp1
m
R
N
A
 r
el
at
iv
e 
ex
pr
es
si
on
**
**
** **
*** ***
* **
**
***
20
Dio2 Ppara
Floxed
H3atKO
Prdm16
0
10
20
30
40
Extracellular matrix
50
80
Mitochondrion
100
Adrb3 Vegfa Pparg
0
5
10
15
20
25
Fabp4 Adipoq Glut4 Plin
Floxed
25 
H3atKO
m
R
N
A
 r
el
at
iv
e 
ex
pr
es
si
on
Cytoskeleton
2 4
Enrichment score
151050
Enrichment score
a DOWN REGULATED GENES
0
Metal binding
Membrane
Mitochondrion
Cell junctions
Cell–cell adhesion
10
RHO protein signal
LIM binding domain
40
5
Cell red-ox homeostasis
Dioxygenase activity
% of genes in the pathway
EGF-like domain proteins
Microtubules
Ribosomal proteins
Protein kinases
30
15
PDZ domain proteins
WD40/YVTN repeat-like
Collagen
Endoplasmic reticulum
Semaphorin
Protein deubiquitination
IFNy signaling
Circadian rhythm
11
Dnaj domain
20
Ubiquitin conjugating
B and T-cells homeostasis
12
25
10
Cell cycle
% of genes in the pathway
Endoplasmic reticulum
6 8
Respiratory chain
20
Protein transport
10
Protein kinase
Oxidoreductase activity
50
Protein biosynthesis
Peroxisome
0
Fatty acid metabolism
GTPase activity
Transcription regulation
0
Protein transport
Metal binding
b
d
UP REGULATED GENES
c
Fig. 2 Differential transcriptome proﬁle in IngWAT of ﬂoxed vs. H3atKO mice. a Down-regulated pathways in IngWAT of H3atKO mice; b Upregulated
pathways in IngWAT of H3atKO mice (n= 3 per group, where each sample represents a pool from 2 individual mice); c, d qPCR gene expression analysis
of browning genes and adipose markers in IngWAT of ﬂoxed and H3atKO mice (n= 9–11 per group). Data in c and d are presented as mean± s.e.m.
Statistical analysis: Student’s t-test, *p< 0.05, **p< 0.01, and ***p< 0.001
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Fig. 3 Adipose ablation of Hdac3 remodels WAT metabolism. a Heatmap of IngWAT metabolome in ﬂoxed and H3atKO mice (n= 7–8 per group);
b Volcano plot of IngWAT metabolome in ﬂoxed and H3atKO mice (n= 7–8 per group). c Levels of acetyl-CoA and citrate in IngWAT of ﬂoxed
and H3atKO mice (n= 7–8 per group); d Expression analysis of genes involved in citrate mitochondrial export in IngWAT of Hdac3 ﬂoxed and H3atKO mice
(n= 9–11 per group); e Levels of glycolysis intermediates in IngWAT of ﬂoxed and H3atKO mice (n= 7–8 per group); f Expression analysis of genes
involved in glucose metabolism in IngWAT of Hdac3 ﬂoxed and H3atKO mice (n= 9–11 per group); gWestern blot and quantiﬁcation of pSer-293 PDHE1α,
pSer-300 PDHE1α, and PDHE1α, α-Tubulin in IngWAT of Hdac3 ﬂoxed and H3atKO mice (n= 3 per group). Data are presented as mean± s.e.m. Statistical
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contribute to improve the response to cold. RNA sequencing was
performed in IngWAT from a subset of ﬂoxed and H3atKO
animals fed standard diet for an initial characterization of tran-
scriptome. Interestingly, we found that several genes were dif-
ferentially regulated in IngWAT in response to adipose ablation
of HDAC3 (Fig. 2a, b). Among upregulated transcripts we found
genes belonging to functional annotations related to mitochon-
dria, FA metabolism and Krebs cycle, indicating activation of
exceptional oxidative program in white adipocytes upon HDAC3
deletion. Of note, several other genes were down-regulated in
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H3atKO mice, indicating that ablation of this transcriptional
repressor did not de-repress globally the entire transcriptome
(1429 upregulated transcripts and 2246 down-regulated tran-
scripts). Based on the results of RNA sequencing we decided to
conduct quantitative PCR (qPCR) analysis on speciﬁc panels of
genes, playing a role in adipose physiology and in WAT
browning. We conﬁrmed increased expression of classical brown
fat marker genes (Ucp1, Dio2, Ppara, Prdm16, Adrb3, and Vegfa2;
Fig. 2c) and, concomitantly, higher expression of markers of
adipocyte functionality (Pparg, Glut4, Fabp4, Adipoq, and Plin;
Fig. 2d) as well as of genes involved in oxidative metabolism
(Idh3a, Bckdhb, Cox7a1, and Ppargc1a; Supplementary Fig. 1e)
that clearly indicate transcriptional remodeling of IngWAT.
Likewise, EpiWAT of H3atKO mice showed similar though
milder phenotype, with no signiﬁcant differences in adipocyte
morphology compared to ﬂoxed mice (Supplementary Fig. 2d)
but increased expression of browning genes, adipose markers, and
oxidative metabolism genes (Supplementary Fig. 2e–g). Of
note, levels of serum triglycerides (Supplementary Fig. 1f) and
non-esteriﬁed FAs (NEFA) (Supplementary Fig. 1g) were reduced
in H3atKO mice, while serum cholesterol levels did not differ
(Supplementary Fig. 1h). Finally, livers from H3atKO, in which
Hdac3 was not ablated (Supplementary Fig. 1i), did not show
signs of lipid steatosis, as shown by hematoxylin and eosin
staining (Supplementary Fig. 1j).
The increased thermogenic activity during cold exposure in
H3atKO mice prompted us to analyze BAT from ﬂoxed and
H3atKO mice. Surprisingly, we found that Hdac3 ablation in
brown fat of mice housed at room temperature did not reprogram
the expression of brown markers, except Dio2, nor that of
genes involved in glucose and lipid metabolism (Supplementary
Fig. 3c, f, g). More importantly, the expression of UCP1 protein
did not increase in BAT of H3atKO mice (Supplementary
Fig. 3d). HDAC3 is part of transcriptional repressor complexes
and could potentially be involved in the maintenance of
phenotypic features of different organs, including BAT. Thus,
to assess whether Hdac3 ablation unselectively de-repressed
expression of genes typically not expressed in brown adipose
tissue, we analyzed the expression of white fat selective markers
(Retn, Ednra, Serpina3k, and Psat1) in BAT and found that none
of these markers was increased in H3atKO mice (Supplementary
Fig. 3e). In order to unveil the possible contribution of BAT to
improved thermogenic function in H3atKO mice upon cold
challenge, we analyzed gene expression proﬁle in BAT of mice
exposed to 4 °C for 24 h. We found no differences in the
expression of brown markers and of most metabolic genes
between ﬂoxed and H3atKO mice (Supplementary Fig. 3h).
Furthermore, hematoxylin and eosin staining did not reveal
morphological modiﬁcations between the two groups (Supple-
mentary Fig. 3i). Altogether, these results indicate that Hdac3
ablation selectively remodels white fat phenotype, revealing
HDAC3 as an epigenetic regulator of WAT metabolism and
function.
HDAC3 ablation remodels white adipose tissue metabolome.
The profound differences of expression of metabolic genes in
BAT and WAT (Fig. 1a) lead us to investigate whether browning
occurring upon Hdac3 ablation in WAT even in the absence of
cold exposure determined a metabolic rewiring of this tissue.
Metabolomic analysis of IngWAT unveiled a differential pattern
of metabolites related to glycolysis and TCA cycle, FAs, and acyl
carnitines in H3atKO vs. ﬂoxed mice (Fig. 3a). Volcano plot
(Fig. 3b, Supplementary Table 1) showed that the metabolite
mostly modulated upon Hdac3 ablation was citrate, whose levels
were reduced along with that of acetyl-CoA in IngWAT (Fig. 3c).
To explain these metabolic changes, we measured the expression
of genes involved in citrate metabolism: we detected increased
expression of citrate synthase (Cs) in H3atKO mice (Fig. 3d),
suggesting that oxaloacetate could condensate to acetyl-CoA to
form citrate. Further gene expression analysis also demonstrated
induction of the gene encoding the mitochondrial citrate carrier
Slc25a1, which exports citrate from mitochondria to cytosol. The
expression of the gene encoding for the ATP citrate lyase (Acly)
cleaving citrate to acetyl-CoA and oxaloacetate (Fig. 3d) increased
in H3atKO mice, explaining the reduction of citrate observed in
these mice. Further metabolomic analysis also revealed reduced
levels of glucose, glucose 6-phosphate, fructose 1,6-bisphosphate,
and dihydroxyacetone phosphate/glyceraldehyde 3-phosphate in
H3atKO (Fig. 3e), indicating reduced accumulation of glycolysis
intermediates, potentially consistent with greater conversion of
glucose to pyruvate. A similar gene expression proﬁle
was observed in EpiWAT from H3atKO mice (Supplementary
Fig. 4a, b). In analogy to BAT (Fig. 1a), the expression of pyruvate
kinase Pkm and Pdk4 was highly augmented in IngWAT of
H3atKO mice (Fig. 3f). Western blot analysis of pyruvate dehy-
drogenase (PDHE1α) showed increased phosphorylation at serine
293 and 300 (Fig. 3g) in IngWAT of H3atKO mice, correlating
with reduced activity of the protein20. These results indicate that
Hdac3 deletion stimulates glycolysis, but at the same time
prevents the conversion of pyruvate to acetyl-CoA.
Metabolome analysis showed that both levels of pyruvate and
lactate (Supplementary Fig. 5a) were reduced in WAT from
H3atKO, excluding that in our model pyruvate is converted to
lactate. In this regard, increased expression of Mpc1 and Pcx in
knock out mice (Fig. 3f) suggested that pyruvate entered into
mitochondria, where it is converted to oxaloacetate. The
expression of cytosolic PEPCK (Pck1) showed a robust increase in
H3atKO mice (Fig. 3f). Of note, this enzyme has been proposed
to play a relevant role in BAT metabolism and non-shivering
thermogenesis21. We also found that intermediates of the pentose
phosphate pathway were reduced in H3atKO mice (Supplemen-
tary Fig. 5b). Moreover, we found lower levels of TCA cycle
intermediates in KO mice (Supplementary Fig. 5c), possibly as a
consequence of considerable citrate export from mitochondria.
These results point out that adipose ablation of Hdac3 profoundly
remodeled metabolome in WAT, most likely as a consequence of
reset gene expression program.
Fig. 4 Hdac3 ablation activates a futile cycle of FA metabolism in adipocytes. a IngWAT fatty acid quantiﬁcation by mass spectrometry in ﬂoxed
and H3atKO mice (n= 7–8 per group); b Malonyl CoA levels in IngWAT of ﬂoxed and H3atKO mice (n= 7–8 per group); c Expression of lipolysis and
FA β-oxidation genes in IngWAT of ﬂoxed and H3atKO mice (n= 9–11 per group); d Western blot analysis and quantiﬁcation of ATGL and ACADL in
IngWAT of ﬂoxed and H3atKO mice (n= 3 per group); e Expression of lipogenic genes in IngWAT of ﬂoxed and H3atKO mice (n= 9–11 per group);
expression of Acly gene was the same reported in Fig. 3d; f Experimental paradigm of differentiation and infection of C3H/10T1/2 cells; g Western
blot analysis of HDAC3, showing the deletion of the protein in cells infected with adenovirus expressing a shRNA targeted to Hdac3 (shHDAC3) vs. cell
infected with a scrambled control shRNA (scramble; n= 3); h Expression of browning genes in scramble and shHDAC3 infected cells (n= 4 biological
replicates per group); i Morphology of scramble and shHDAC3 infected cells, scale bar is 50 μm.; j Expression of lipolytic and lipogenic genes in
scramble and shHDAC3 infected cells (n= 4 biological replicates per group); k Glycerol release in scramble and shHDAC3 infected cells (n= 10 per
group); l–n 13C-labeled acetyl-CoA, citrate, and palmitate in scramble and shHDAC3 infected cells (n= 6 per group). Data are presented as mean± s.e.m.
Statistical analysis: Student’s t-test, *p< 0.05, **p< 0.01, and ***p< 0.001
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Lack of HDAC3 elicits a futile cycle of FA metabolism in WAT.
A distinctive hallmark of BAT metabolism is the concomitant
activation of lipolytic and lipogenic pathways to sustain energy
demand related to thermogenic potential17–19. Interestingly, cold
exposure activates a similar reprogramming of lipid metabolism
in WAT via β3-adrenergic receptor22. Thus, we completed the
metabolomics approach with lipidomics analysis in WAT of
ﬂoxed and H3atKO mice, which revealed a reduction of saturated
and unsaturated FAs in H3atKO (Fig. 4a) in the IngWAT.
Decreased levels of FAs in adipose tissue may be suggestive of a
higher utilization of fat as energy source in this depot. In this
regard, mass spectrometry analysis showed that the allosteric
inhibitor of CPT1 malonyl-CoA was reduced in IngWAT of
H3atKO mice (Fig. 4b), thus favoring mitochondrial FA transport
and β-oxidation. Accordingly, we detected an upsurge of
the expression of lipolytic genes (Lipe and Atgl), peroxisomal FA
β-oxidation (Acox1) and mitochondrial FA β-oxidation (Acsl1,
Cpt1b, Slc25a20, Acadl, Acadm, and Hadh; Fig. 4c). Western blot
analysis conﬁrmed signiﬁcant increased protein expression of
adipose tissue triglyceride lipase (ATGL) and of long chain acyl-
CoA dehydrogenase (ACADL; Fig. 4d). The expression of genes
involved in de novo FA synthesis (ChREBPβ, Srebp1c, Acly, Fasn,
Acaca, G6pd2, and Me3) was upregulated in H3atKO mice
(Fig. 4e), corroborating the hypothesis that the browning effect
observed in these mice is sustained by a metabolic rewiring that
phenocopies BAT metabolism. Similar, albeit less pronounced,
effects in gene expression and FA proﬁle occurred in epididymal
fat (Supplementary Fig. 4c–e). As expected, cold exposure
increased the expression of browning markers in IngWAT from
mice exposed to 4 °C for 24 h (Supplementary Fig. 6), and simi-
larly to Hdac3 ablation, increased expression of glucose-related
genes (Glut4 and Pdk4) and of genes involved in citrate export
and FA synthesis/β-oxidation (Supplementary Fig. 6). Interest-
ingly, H3atKO mice exposed to cold showed less marked effects
when compared to ﬂoxed under the same temperature condition
(Supplementary Fig. 6).
It has been demonstrated that the high rate of FA β-oxidation
correlates with increased levels of short-chain acylcarnitines23.
Nonetheless, mass spectrometry analysis yielded unexpected
results as the levels of most acylcarnitines in both inguinal
(Supplementary Fig. 7a) and epididymal WAT (Supplementary
Fig. 7b) showed a reduction in H3atKO mice. To explain the
decreased levels of acylcarnitines in H3atKO mice we hypothe-
sized that FAs are shortened via peroxisomal β-oxidation and that
acetyl-CoA from FA β-oxidation in adipose tissue of H3atKO
mice is immediately used for de novo FA synthesis. Consistent
with increased peroxisomal FA β-oxidation we also detected
increased expression of Acox1 (Fig. 4c) and Catalase, the
latter involved in detoxiﬁcation of H2O2 resulting from
peroxisomal β-oxidation. To demonstrate the onset of a futile
cycle of FA metabolism consequent to HDAC3 inactivation, we
used a cellular model of preadipocytes, C3H/10T1/2. Preadipo-
cytes were infected with scramble adenovirus or with adenovirus
delivering short hairpin RNA to silence Hdac3 (shHDAC3;
Fig. 4f). Silencing of HDAC3 in cells was assessed by western blot
(Fig. 4g). This cellular model recapitulated the in vivo effects of
Hdac3 deletion: in vitro inactivation of Hdac3 caused the
induction of browning genes (Fig. 4h), and promoted adipocyte
differentiation, as demonstrated by the greater number of
differentiated cells (Fig. 4i) and by the increased lipid accumula-
tion in ORO staining (Supplementary Fig. 8a). Accordingly,
shHDAC3 treated cells showed increased expression of adipocyte
markers (Supplementary Fig. 8b). Gene expression analysis also
conﬁrmed that silencing of Hdac3 in C3H/10T1/2 adipocytes
increased the expression of genes of glucose and citrate
metabolism (Supplementary Fig. 8c) and of lipolysis, FA β-
oxidation and FA synthesis genes (Fig. 4j). The increased rate of
lipolysis was conﬁrmed by higher glycerol release in shHDAC3
cells (Fig. 4k). Administration of [U-13C]Palmitate (where U
denotes uniformly labeled) demonstrated that silencing of Hdac3
determined higher β-oxidation rate, as conﬁrmed by increase of
13C-Acetyl-CoA (+1) (Fig. 4l), coming from β-oxidation of
labeled palmitate (Supplementary Fig. 9). No differences in the
levels of 13C-Acetyl-CoA (+2) between scramble and shHDCA3-
silenced cells were detected (Fig. 4l). Higher levels of 13C-Acetyl-
CoA (+1) were paralleled by decreased levels of 13C-Citrate (+1)
(Fig. 4m), conﬁrming that silencing of HDAC3 promoted
the activity of ATP citrate lyase, which converts citrate into
acetyl-CoA. This result was in line with the upregulation of the
gene (Acly) encoding for this enzyme (Fig. 4j). 13C-isotopologue
labeling experiments also demonstrated that shHDAC3 silenced
cells showed higher levels of 13C-Citrate (+4) (Fig. 4m), whose
formation requires that 2 molecules of 13C-Acetyl-CoA (+2),
coming from labeled palmitate, entered the TCA cycle (Supple-
mentary Fig. 9). No differences in the levels of 13C-Citrate (+2)
and 13C-Citrate (+5) between scramble and shHDCA3-silenced
cells were detected (Fig. 4m). Increased 13C-Acetyl-CoA (+1) and
13C-Citrate (+4) levels conﬁrmed that silencing of Hdac3 boosted
mitochondrial FA β-oxidation and TCA cycle. Moreover, we
found higher level of 13C-Palmitate (+2) in shHDAC3 cells
(Fig. 4n and Supplementary Fig. 9) and a trend of increased of
13C-Malonyl-CoA (+2, +3) (Supplementary Fig. 8d), corroborat-
ing de novo FA synthesis from β-oxidized FAs under this
condition. 13C-Acetyl-CoA (+2) is incorporated in 13C-Palmitate
(+2), thus explaining the lack of increase of this isotopologue in
shHDAC3 cells. These in vitro experiments demonstrated that
adipose ablation of HDAC3 triggers FA futile cycle in white fat.
HDAC3 deletion selectively remodels histone acetylation. To
investigate the molecular mechanisms underlying the effect
of HDAC3 ablation in white adipocytes, we focused on histone
post-translational modiﬁcations as read out of HDAC3 activity.
First we tested whether HDAC3 deletion correlated with
increased histone acetylation. Consistent with evidences reported
by other authors7, 24, acidic extraction of histones resulted in no
differences in global pan- and lysine 27 acetylation on histone H3
in mice and cells lacking HDAC3 (Supplementary Fig. 10a, b).
Additionally, in order to investigate whether acetyl-CoA coming
from FA β-oxidation could be a source of acetyl groups for
histone acetylation, we performed a mass spectrometry analysis of
histone H3 (acid extracted) from C3H10T1/2 cells infected with
scramble or HDAC3 short hairpin RNAs (shRNAs), incubated
with [U-13C]-Palmitate. Consistent with the western blots, mass
spectrometry analysis showed no statistical signiﬁcant differences
in acetylation status of 9–17, 18–26, 27–40, 54–63, 73–83,
and 117–128 peptides (Supplementary Fig. 10c). More inter-
estingly, we were able to show incorporation of labeled carbons
(13C acetylation) on 9–17, 18–26, and 27–40 peptides, with no
differences between scrambled and knock down cells. Peptide
27–40 contains 3 lysine residues that could be acetylated (Lys 27,
36, and 37). Therefore, we speciﬁcally investigated the acetylation
status of lysine 27, a known mark of active enhancers, and
quantiﬁed the amount of 12C- vs. 13C-acetylation in
scrambled or HDAC3 silenced cells (Supplementary Fig. 10d).
Since we detected that most acetyl groups showed labeled carbons
(13C-acetylation) in both conditions, we conﬁrmed that acetyl-
CoA, derived from FA β-oxidation, was a source of acetyl groups
for histone acetylation on lysine 27. This result corroborated data
by 13C-isotopologue labeling experiments (Fig. 4l–n): knock
down of HDAC3 in fact increased β-oxidation and amount
of labeled acetyl-CoA, but concomitantly this was in part used for
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de novo synthesis of FA. This possibly caused the lack of
increased 13C acetyl-CoA incorporation on histone H3.
It has been reported that selective deletion of HDAC3
increased acetylation of speciﬁc chromatin regions, even though
global histone acetylation did not change7. Thus, we focused on
“hot regions”, whose epigenomic regulation might be crucial for
the transcriptional and metabolic phenotype of H3atKO mice.
Since Hdac3 deletion increased expression of the master regulator
of adipocyte differentiation, Pparg, and of its main targets, we
looked at acetylation status of this gene. It has been recently
demonstrated that H3K27ac marks a potent enhancer of Pparg
gene25 (Fig. 5a), thus we performed a ChIP analysis of H3K27ac
and found increased acetylation on Pparg enhancer in shHDAC3
treated cells and in IngWAT of H3atKO mice (Figs. 5b, c).
Another key gene upregulated upon Hdac3 inactivation is
Ucp1: two enhancers located 13 and 5 kb upstream of the
transcription start site (TSS) of Ucp1 are hyperacetylated
(H3K27ac) in differentiating brown adipocytes15 (Fig. 5a). ChIP
analysis showed increased H3K27 acetylation in cells lacking
HDAC3 (Fig. 5b), while only −5kb enhancer resulted in
hyperacetylated in IngWAT of H3atKO mice (Fig. 5c). Moreover,
by reviewing published H3K27ac ChIP-Seq data (GSE63964), we
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noticed hyperacetylation of H3K27 in regions located 15, 11, 3.5,
and 1.6 kb upstream of the TSS of Ppara gene in BAT
samples, while the same regions were not acetylated in WAT
samples (Fig. 5d, Supplementary Fig. 11a). PPARα is in fact
highly expressed in BAT and directly regulates Pdk4 and FA β-
oxidation genes26. Thus, we analyzed H3K27 acetylation in these
putative regulatory regions and found that −15 and −11 kb
regions showed signiﬁcant increase in H3K27ac in shHDAC3
cells and in IngWAT of mice lacking HDAC3 (Fig. 5e, f).
Moreover, H3K27 acetylation increased in the −1.6 kb region in
IngWAT of H3atKO mice (Fig. 5f). Interestingly, H3K27ac ChIP
analysis in BAT from ﬂoxed and H3atKO mice showed no
differences in the acetylation of Pparg and Ucp1 enhancers
(Supplementary Fig. 11b), and of putative regulatory regions of
Ppara (Supplementary Fig. 11c), conﬁrming that HDAC3 does
not play a role in determining the phenotype of BAT, as opposed
to WAT.
ACLY is required to establish the phenotype of H3atKO mice.
In WAT from H3atKO mice we detected increased expression of
Acly gene (Fig. 4e), encoding the cytosolic enzyme belonging to
the FA biosynthetic pathway that converts citrate to acetyl-CoA
and oxaloacetate27. However, the reaction catalyzed by ACLY also
represents the major source of acetyl-CoA for histone acetylation
in mammalian cells13. Notably, immunoﬂuorescence analysis of
ACLY in IngWAT from ﬂoxed and H3atKO mice demonstrated
that this enzyme localized also in the nucleus, and most strikingly
we detected higher nuclear localization in knock out mice
(Fig. 6b). Nuclear ACLY catalyzes the reaction that could locally
provide acetyl groups to sustain chromatin hyperacetylation
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observed in Pparg and Ucp1 enhancers and in Ppara putative
regulatory regions. To demonstrate that acetylation of these
regions in adipocytes lacking HDAC3 was dependent on the
increased acetyl-CoA arising from ACLY-mediated cleavage of
citrate, we co-silenced both ACLY and HDAC3 in C3H/10T1/2
cells with shRNAs. Efﬁciency of ACLY knock down was
conﬁrmed by western blot (Supplementary Fig. 12a) and by qPCR
(Fig. 6d). Interestingly, we found that ACLY silencing completely
blocked adipogenesis as shown by dramatically decreased number
of differentiated adipocytes (Fig. 6c, third panel) and by reduced
expression of adipose markers Pparg and Glut4 (Fig. 6d, black
bars). Most importantly, co-silencing of ACLY and HDAC3
completely abrogated the effects of HDAC3 inactivation, since
few cells appeared fully differentiated to adipocytes (Fig. 6c,
fourth panel). Expression analysis showed that genes that were
strongly induced upon HDAC3 silencing (Ucp1, Ppara, Pparg,
Glut4, Pdk4, Pcx, Atgl, Acadl, and Fasn), were signiﬁcantly
reduced in cells lacking ACLY as well as in cells lacking both
HDAC3 and ACLY (Fig. 6d). ChIP analysis showed signiﬁcant
reduction of H3K27 acetylation on −5 kb Ucp1 enhancer and on
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Ppara putative regions in co-silenced cells compared to
shHDAC3 treated cells, while a 50% reduction, though not
statistically signiﬁcant, was observed for Pparg enhancer (Fig. 6e).
Since these results clearly demonstrate the pivotal role of ACLY
in determining the phenotype of HDAC3 knocked down cells, we
infer that ACLY is a central player in the transcriptional and
metabolic outcome of Hdac3 ablation in mice. Another potential
source of acetyl groups for de novo FA synthesis is acetate that
can be converted to acetyl-CoA by cytosolic acetyl-CoA synthe-
tase (ACSS2). Interestingly, Acss2 gene was strongly induced in
IngWAT of H3atKO mice (Supplementary Fig. 12b). However,
knock down of ACSS2 (Supplementary Fig. 12c) did not affect
adipocyte morphology (Supplementary Fig. 12d) and gene
expression (Supplementary Fig. 12e) when compared to scramble
shRNA. Also, as opposed to ACLY shRNA, co-silencing of ACSS2
and HDAC3 by shRNA did not result in any morphological or
transcriptional (Supplementary Fig. 12d, e) effect as compared to
cells treated with shHDAC3. Our results mirror the observations
of Wellen et al.13 who showed that ACLY is the key player in
coordinating nuclear activity (that is, chromatin acetylation)
and cellular metabolism, whereas ACSS2, the other enzyme
potentially providing extra mitochondrial acetyl-CoA, plays a
minor or an ancillary role in these processes.
No effect of Hdac3 KO on lipid metabolism with high fat diet.
Having observed profound remodeling of WAT metabolism in
H3atKO mice, we investigated whether adipose ablation of
HDAC3 was able to prevent or attenuate diet-induced obesity. To
this end, Hdac3 ﬂoxed and knock out mice were fed for 24 weeks
with an obesogenic high fat diet (HFD). Intriguingly, we found no
differences in body weight gain (Fig. 7a) and in glucose tolerance
(Fig. 7b). Metabolomic analysis (Fig. 7c, d, Supplementary
Table 2) of IngWAT showed that effects on glycolysis, TCA cycle
metabolites (Supplementary Fig. 13a–c), intermediates of the
pentose phosphate pathway (Supplementary Fig. 13d), FAs
(Supplementary Fig. 13e), and acyl carnitines (Supplementary
Fig. 13f), observed in H3atKO fed LFD, were lost in mice fed
HFD. Accordingly, expression analysis of genes related to glucose
and citrate metabolism (Supplementary Fig. 14a, b) showed no
change. Genes involved in lipolysis and FA β-oxidation
were not signiﬁcantly upregulated in knock out mice (Fig. 7h,
Supplementary Fig. 14c), while among genes of FA synthesis only
Fasn was signiﬁcantly increased, though to a lesser extent (6-fold
increase in H3atKO, Fig. 7h) as compared to mice fed low fat
diet (LFD, 43-fold increase in H3atKO, Fig. 4e). Moreover, no
morphological differences in inguinal adipocytes from ﬂoxed and
H3atKO mice were highlighted by histological analysis (Fig. 7e).
As a consequence of the lack of metabolic remodeling, IngWAT
of H3atKO mice fed HFD did not undergo browning, as cold
challenge experiment showed no differences in maintenance of
body temperature in ﬂoxed and H3atKO mice exposed to 4 °C
(Fig. 7f), and browning genes were not upregulated in knock out
mice (Fig. 7g). Also, upregulation of adipocyte functionality genes
(including Pparg) and of oxidative metabolism genes was lost
upon HFD feeding (Supplementary Fig. 14c). No difference in
global pan- and lysine 27 acetylation of histone H3 was detected
upon Hdac3 ablation (Supplementary Fig. 15a, b). Moreover, we
found low expression of Acly in HFD fed mice, and no upregu-
lation of this gene in response to Hdac3 ablation (Supplementary
Fig. 15c). This result was paralleled by immunoﬂuorescence
analysis, showing no differences in the number of
ACLY positive nuclei in IngWAT of ﬂoxed and knock out mice
(Supplementary Fig. 15d, e), and a statistically signiﬁcant
reduction of ACLY positive nuclei compared to ﬂoxed and
H3atKO fed LFD (Supplementary Fig. 15d, e). Accordingly, ChIP
analysis demonstrated that ablation of Hdac3 did not affect
H3K27 acetylation of Pparg and Ucp1 enhancers, and of Ppara
putative regulatory regions in presence of a high fat feeding
(Figs. 7i, j).
As shown above, the peculiar phenotype observed in H3atKO
is sustained by rewiring of lipid metabolism, with concomitant
activation of FA synthesis and β-oxidation genetic networks
resulting in the onset of a futile cycle. To gain insight on how
HFD overcomes the metabolic and transcriptional effects of
adipose ablation of Hdac3, we focused on lipid metabolic
pathways that can be modulated in adipose tissue upon high fat
feeding. It has been demonstrated that HFD reduces lipolysis
mediated by cathecolamines in adipose tissue, and that high fat
feeding reduces levels of lipases28. Among these, particularly
relevant is ATGL, since its activity is fundamental to feed the
futile cycle of FAs in adipose tissues during β3-adrenergic
activation and to maintain brown-like phenotype22. We
measured ATGL expression in IngWAT of ﬂoxed and H3atKO
mice fed LFD or HFD and we found that ablation of Hdac3
increased expression of ATGL with both diets. However, when
fed HFD ﬂoxed and knock out mice showed signiﬁcantly lower
levels of ATGL as compared to H3atKO LFD fed mice (Fig. 8a).
This observation suggests that the lipolytic activity of IngWAT
releasing free FAs (FFAs) is reduced upon HFD feeding. Notably,
knock down of ATGL in brown adipocytes prevented induction
of genes involved in FA β-oxidation, owing to lack of lipolytic
products (FFAs) that act as ligands for PPARs29. In our model a
key gene regulated upon Hdac3 ablation in IngWAT is Pdk4,
whose protein product phosphorylates and inactivates pyruvate
dehydrogenase (PDHE1α), thus allowing the entrance of
oxaloacetate in the TCA cycle to form citrate. Importantly,
Pdk4 is transcriptionally activated by PPARα7. As previously
shown (Fig. 7j), H3K27 hyperacetylation on Ppara putative
Fig. 8 Role of PPARα and ChREBPβ in lipolysis and lipogenesis in WAT and in adipocytes. a Western blot analysis and quantiﬁcation of ATGL in IngWAT
from ﬂoxed and H3atKO mice fed LFD or HFD (n= 2, where each replicate represent a pool of samples from 3 mice); b, c mRNA expression of Ppara and
Pdk4 in IngWAT from ﬂoxed and H3atKO mice fed LFD or HFD (n= 9–11 for LFD mice, n= 5 per group for HFD samples); dWestern blot and quantiﬁcation
of pSer-293 PDHE1α, pSer-300 PDHE1α, PDHE1α in IngWAT of Hdac3 ﬂoxed and knock out mice fed LFD or HFD (n= 2, where each replicate represent
a pool of samples from 3 mice); Data are presented as mean± s.e.m. Statistical analysis: two way ANOVA, Tukey as post hoc test, *p< 0.05, **p< 0.01,
***p< 0.001 vs. Floxed LFD, #p< 0.05, ##p< 0.01, ###p< 0.001 vs. H3atKO LFD, §p< 0.05, §§p< 0.01, §§§p< 0.001 vs. Floxed HFD. e Western blot and
quantiﬁcation of pSer-293 PDHE1α, pSer-300 PDHE1α, PDHE1α in cells infected with adenovirus expressing shRNA targeted to Hdac3 or to a scrambled
control shRNA (scramble) and differentiated in presence of vehicle or 10 μM GW6471 (n= 2, where each replicate represent a pool of 3 samples);
f Morphology of cells infected with adenovirus expressing shRNA targeted to Hdac3 or to a scrambled control shRNA (scramble) and differentiated in
presence of vehicle or 10 μM GW6471, scale bar is 50 μm; g Gene expression analysis on mRNA from cells infected with adenovirus expressing shRNA
targeted to Hdac3 or to a scrambled control shRNA (scramble) and differentiated in presence of vehicle or 10 μM GW6471 (n= 3 per group). Data
are presented as mean± s.e.m. Statistical analysis: two-way ANOVA, Tukey as post hoc test, *p< 0.05, **p< 0.01, and ***p< 0.001 vs. Scramble + Vehicle,
#p< 0.05, ##p< 0.01, and ###p< 0.001 vs. shHDAC3 + Vehicle, §p< 0.05, §§p< 0.01, and §§§p< 0.001 vs. Scramble + GW6471. h–j mRNA expression of
ChREBPβ, Glut4, Pparg in IngWAT of Hdac3 ﬂoxed and knock out mice fed LFD or HFD (n= 9–11 for LFD mice, n= 5 per group for HFD samples); Two-way
ANOVA, Tukey as post hoc test, *p< 0.05, **p< 0.01, and ***p< 0.001 vs. Floxed LFD, #p< 0.05, ##p< 0.01, and ###p< 0.001 vs. H3atKO LFD
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regulatory regions in response to Hdac3 ablation was blunted in
IngWAT of HFD fed mice. Consequently, Ppara expression was
signiﬁcantly reduced in ﬂoxed and H3atKO mice fed HFD when
compared to H3atKO mice fed LFD (Fig. 8b). Moreover, HFD
feeding, by blocking ATGL reduced the availability of FFAs for
PPARα activation. As a result of lower transcription and
activation of PPARα, we detected lower expression of Pdk4 in
ﬂoxed and H3atKO mice fed HFD when compared to H3atKO
mice fed LFD (Fig. 8c). Moreover, HFD reduces phosphorylation
of PDHE1α at Ser29330. In fact, both Ser293 and Ser300 resulted
signiﬁcantly less phosphorylated in ﬂoxed and H3atKO mice fed
HFD (Fig. 8d), suggesting that the PDHE1α kinase activity of
PDK4 in WAT from these mice was reduced. To elucidate the
role of PPARα as mediator of effects of metabolic remodeling
induced by Hdac3 ablation, cells infected with scramble or
HDAC3 shRNAs were treated with vehicle or with the PPARα
antagonist GW6471, to mimic in vitro the lack of activation
of PPARα that occurs in HFD regimen. Hdac3 knock down in
C3H/10T1/2 adipocytes tended to increase phosphorylation
status of PDHE1α, while no increase was found upon treatment
with GW6471 (Fig. 8e). Consistent with published literature31,
treatment with PPARα antagonist decreased the rate of
differentiation (Fig. 8f), reducing expression of adipocyte markers
Pparg and Glut4 (Fig. 8g). Also, the expression of Pdk4 and
other key genes upregulated by shHDAC3 (Ucp1, Acadl, Acly,
and Fasn) was signiﬁcantly reduced in presence of GW6471
(Fig. 8g), implying that ablation of Hdac3 induced expression of
these genes, at least in part, via PPARα.
Another key point in the metabolic remodeling in WAT of
H3atKO mice was the strong activation of a lipogenic program,
that leads to higher level of ACLY, allowing a concomitant
chromatin rearrangement that leads to increased expression of
genes involved in higher metabolic requirements of adipocytes.
As shown above, de novo FA synthesis as well as chromatin
remodeling was abrogated in H3atKO mice fed HFD. It has been
elegantly demonstrated that adipose tissue lipogenesis is primarily
regulated by ChREBP, and that, among ChREBP isoforms, the
most affected by HFD is ChREBPβ isoform32. Interestingly, the
expression of this gene was signiﬁcantly increased in H3atKO
mice fed LFD, but, consistent with published literature, we found
reduction of ChREBPβ upon HFD feeding in both ﬂoxed
and knock out mice (Fig. 8h). Analyzing published H3K27ac
ChIP-Seq data33 (GSE63964), we noticed several regions located
upstream and downstream the TSS for Exon1b of ChREBP gene
(the alternative ﬁrst exon for ChREBPβ isoform) showing
higher H3K27 acetylation proﬁle in BAT vs. WAT samples
(Supplementary Fig. 16a, b). However, H3K27ac ChIP analysis
showed no increase in acetylation status of these putative
regulatory regions in IngWAT of H3atKO compared to ﬂoxed
mice fed LFD (Supplementary Fig. 16c), ruling out that ablation
of HDAC3 drives ChREBPβ expression by directly modulating
histone acetylation levels. Importantly, it is known that ChREBPβ
gene transcription is regulated in response to glucose levels
through ChREBPα and it has been demonstrated that increased
expression of the glucose transporter Glut4 correlates with
higher ChREBPβ expression32. Glut4 in adipose tissue is
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Fig. 9 Transcriptional and metabolic switch occurring in WAT of Hdac3 KO mice. Metabolism and epigenetic remodeling are complementary and mutually
interconnected as each of these phenomena could inﬂuence the other, giving rise to a speciﬁc changes in cellular physiology. In our model, genetic ablation
of the epigenetic modiﬁer HDAC3 in WAT imposes a futile cycle of fatty acid utilization and synthesis that provides acetyl-CoA to remodel speciﬁc
chromatin regions, ultimately determining WAT browning. High-fat diet feeding perturbs this subtle equilibrium and prevents the epigenome remodeling
required for rewiring metabolism in WAT
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transcriptionally regulated by PPARγ34. Accordingly, we found
strong upregulation of Glut4 and Pparg genes in H3atKO mice
fed LFD, while the expression of these genes was reduced in mice
fed HFD (Fig. 8i, j). These results mirror ChIP and gene
expression analyses, showing signiﬁcant increase of Pparg
enhancer H3K27 acetylation and of Pparg expression only in
H3atKO mice fed LFD (Figs. 5c and 7j).
Discussion
In this paper we disentangled the role of the histone modiﬁer
HDAC3 in adipose tissue physiology. The main ﬁnding we report
is that adipose speciﬁc ablation of Hdac3 affects FA metabolism
and induces browning of white fat, promoting the global
thermogenic capacity, without affecting BAT phenotype.
Transcriptome analysis of IngWAT proved that ablation
of HDAC3 did not de-repress globally gene transcription,
demonstrating that the lack of HDAC3 does not lead to general
reactivation of silenced genes. We demonstrated that remodeling
of WAT phenotype is sustained by the metabolic rewiring of
glucose and lipid metabolism (Fig. 9). Our results highlight the
anaplerotic function of glucose/glycolysis to provide oxaloacetate
to TCA cycle in our knock out model. In this frame, FAs
represent an alternative source of acetyl-CoA thus explaining the
exceptional activation of FA lipolysis and β-oxidation in WAT of
mice lacking HDAC3. Concomitantly, mitochondrial citrate is
exported to cytosol, where it is required for de novo lipogenesis.
Thus, by exploiting this animal model, we learnt that WAT
browning induced by HDAC3 ablation activates a “futile cycle” to
meet the high metabolic demand of brown-like fat, whereby FFAs
activate UCP1 and their oxidation provides reduced coenzymes
(that is, NADH and FADH2) required to electron transport chain.
Such futile cycle seems to be operative in tissues with high-energy
expenditure, such as BAT17, 18, 22 as a way to cope with the need
of great amount of energy.
Other authors described a different futile cycle, operating in
brown and beige adipocytes, involving creatine metabolism to
sustain adipose tissue energy expenditure and thermogenic
capacity, demonstrating that creatine enhances respiration in
beige-fat mitochondria when ADP is limiting35. These evidences,
along with our experiments, suggest that beige/brown adipocytes
can trigger paradoxical metabolic pathways to sustain the
incredibly high metabolic demand during thermogenic activation.
We are tempted to speculate that such futile cycle of FA
metabolism could be operative in other tissues in conditions
of high energy requirements, such as skeletal muscle during
sustained physical exercise, or heart. Future investigations will be
required to test this fascinating hypothesis and to verify whether
HDAC3 is involved in the regulation of the metabolic phenotype
in these organs.
Intriguingly, WAT from mice exposed to cold (4 °C) showed
similar proﬁle of Pdk4 expression as well as of genes of FA futile
cycle. Based on these results it is tempting to speculate that Hdac3
ablation phenocopies, at least in part, the transcriptional program
elicited by cold exposure. Future experiments will focus on
whether and how HDAC3 is involved in the adaptive response to
cold exposure.
PDK4 and ACLY, which are upregulated upon Hdac3 ablation,
are key actors in establishing the phenotype of Hdac3 knock out
mice. PDK4 blocks the conversion of pyruvate to acetyl-CoA,
thus making FA β-oxidation the alternative source of acetyl-CoA.
On the other hand, ACLY is a key enzyme in lipogenesis and
also provides acetyl-CoA for histone acetylation. Selective
hyperacetylation of Ucp1 and Pparg enhancers and Ppara putative
regulatory regions in adipocytes lacking HDAC3 are lost
when ACLY is also knocked down concomitantly with HDAC3,
highlighting the crucial role of this lipogenic enzyme in
establishing the phenotype induced upon HDAC3 ablation.
Our results demonstrate that HDAC3 directly regulates Ucp1
transcription, but it also plays a role in the regulation of PPARα
and PPARγ, which are known to drive UCP1 expression36.
PPARα stimulates FA β-oxidation, but it is also essential
in switching off the ﬂow of glucose to acetyl-CoA, which is
channeled to oxaloacetate, by increasing PDK4 expression.
PPARα mediates, at in least in part, the effects of Hdac3 knock
down, as conﬁrmed in the experiment with the antagonist
GW6471. On the other hand, PPARγ may be important for FA
uptake and usage by promoting triglycerides hydrolysis via
LPL and ATGL (PPARγ target genes) that provide FAs as fuel
available for high energy expenditure. Furthermore, PPARγ
regulates Glut4 expression34, favoring glucose internalization and
expression of ChREBPβ, one of the main regulators of lipogenesis
in adipose tissue32. Thus, PPARα and γ emerged as key targets of
HDAC3, whose de-repression upon Hdac3 ablation induces
WAT browning. A key question is how HFD completely offsets
the effects of HDAC3 genetic inactivation. It should be noted that
PPARs are activated by FFAs, mainly resulting from lipolytic
action of ATGL. It has been shown that high fat feeding reduces
protein expression of ATGL28, therefore lower rate of lipolysis
and reduced availability of FFAs are expected to strongly blunt
PPAR activation in both ﬂoxed and Hdac3 knock out mice fed
HFD. The lack of PPARα activation determines lower Pdk4
transcription, resulting in loss of pyruvate dehydrogenase
phosphorylation in HFD fed mice, that allows a different glucose
utilization and reduces the rate of FA β-oxidation. Intriguingly,
high fat feeding also reduced expression of Pparg and Ppara
genes, further reducing the transcription of their target genes.
These effects, paralleled by lower expression of ChREBPβ and
of its lipogenic target genes in response to HFD, disrupt the
epigenetic and metabolic remodeling induced by adipose ablation
of Hdac3. We also demonstrate that when H3atKO mice are fed
HFD the FA futile cycle is less active. Our observations underline
a possible mechanism operative under normal physiological
conditions, which is impaired with an obesogenic diet.
In conclusion, an intrinsic crosstalk between metabolic
pathways and chromatin remodeling (for example, histone
acetylation) emerged by disentangling the complex phenotype of
H3atKO mice and we identiﬁed HDAC3 as a molecular brake of
the ﬂux of acetyl groups from mitochondria to selective regions of
chromatin in white fat. Consequently, genetic ablation of HDAC3
drives transcriptional remodeling of “hot regions” on chromatin,
resulting in a different adipose phenotype, with higher FA
utilization. Any cues (for example, HFD) that alter this
equilibrium between chromatin remodeling and cellular
metabolism may lead to a different phenotypic outcome
(for example, reduced FA utilization).
Altogether, our results shed light on new facets of adipose
tissue physiology, unlocking mechanisms that could be explored
for new approaches in the treatment of adipose tissue dysfunction
related to metabolic disorders.
Methods
Differentiation and infection of C3H/10T1/2 Cells. C3H/10T1/2, Clone 8
(ATCC CCL-226) were used as a cellular model of pre-adipocytes to investigate the
molecular mechanism underlying the effects observed in vivo. Cells were main-
tained in Dulbecco’s modiﬁed Eagle’s medium–10% FBS. To induce
differentiation cells were maintained for 3 days in medium supplemented
with 5 μg/ml insulin, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX, Sigma Aldrich),
2 μg/ml dexamethasone (Sigma Aldrich), 5 μM rosiglitazone (Cayman Chemicals)
and then switched to medium supplemented with 5 μg/ml insulin for 6 days. At the
induction of differentiation cell were infected with 100MOI scramble or shHDAC3
adenovectors (Vector BioLabs) to knockdown HDAC3.
To silence Acly and Acss2, cells were infected with 50MOI shACLY/shACSS2
adenovectors (Vector BioLabs). To perform co-silencing of Hdac3 and Acly/Acss2,
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cells at the induction of differentiation were infected with 100MOI shHdac3 + 50
MOI shAcly or 100MOI shHdac3 + 50MOI shAcss2. In this case, cells infected
with 150MOI Scramble were used as negative controls.
To evaluate the role of Pparα in the metabolic rewiring consequent to Hdac3
ablation, cells were co-treated with 100MOI Scramble or shHdac3 and vehicle
(DMSO) or 10 μM GW6471 (Sigma Aldrich) at the induction of differentiation for
3 days, then medium was supplemented with 5 μg/ml insulin and vehicle/GW6471
for the following 6 days.
13C Tracing analysis. At day 9 of differentiation C3H/10T1/2 cells previously
infected with Scramble or shHDAC3 adenoviral vectors were treated with 100 μM
[U-13C]Palmitate (Sigma Aldrich) and 1 mM Carnitine (Sigma Aldrich) for 30
min. [U-13C]Palmitate and Carnitine solutions were prepared as described
previously37. Methanolic extracts of cells were analyzed by electrospray ionization
ﬂow injection analysis tandem mass spectrometry (FIA-MS/MS). For citrate,
acetylCoA, palmitate, and malonylCoA each isotopomer was resolved by m/z ratios
and quantiﬁed by Mass Distribution Vector (MDV), as described previously38.
Then, the percentage of MDV for each isotopomer was normalized by protein
content, measured by BCA Assay (Euroclone).
Acidic extraction of histones and mass spectrometry analysis. At day 3 of
differentiation, C3H/10T1/2 cells previously infected with Scramble or
shHDAC3 adenoviral vectors were treated with 500 μM [U-13C]Palmitate (Sigma
Aldrich), 25 μM CoA (Sigma Aldrich), and 1 mM Carnitine (Sigma Aldrich) for 3 h
and then pelleted. Each cellular pellet (three biological replicates for each
condition) was re-suspended carefully in 7.5 ml of N-Buffer (10% Sucrose, 0.5 mM
EGTA, pH 8.0, 60 mM KCl, 15 mM NaCl, 15 mM HEPES, pH 7.5, 30 μg/ml
Spermidine, protease inhibitors cocktail, phosphatase inhibitors cocktail, 1 mM
DTT) and 500 μl of Triton X-100 solution 8% (460 μl of N-Buffer + 40 μl Triton
X-100). The samples were rolled for 10′ at 4 °C. Then each lysate was put onto a
sucrose cushion (2 g of sucrose in 20 ml of N-buffer) and centrifuged at 4,000 rpm
for 20′. The supernatant was removed while the nuclear pellet was washed twice
with 2 ml of ice-cold PBS. Upon the addition of an equal volume of HCl 0.8 N, the
nuclei were extracted overnight at 4 °C rolling. The next day each sample was
centrifuged at 13,000 r.p.m. for 10′. The pellets were re-extracted in 0.4 N HCl for
4 h. All the supernatants were collected and pooled. In order to change the
supernatant buffer 0.4 N HCl buffer to 0.1 M CH3COOH and ﬁnally to water,
AMICON ﬁlters (MWCO 3 kDa, Millipore) were used. Protein concentration was
determined using Direct Detect IR Spectrophotometer (Millipore). 40 µg of each
sample were loaded on a 17.5% Sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE). For the analysis of peptides, the bands corresponding to
H3 histone were excised upon Coomassie staining, reduced with ditiothreitol,
alkylated with iodoacetamide and digested with sequencing grade endoproteinase
Arg-C (Roche Diagnostics). For selective analysis of acetylation of Lysine 27, the
bands corresponding to H3 histone were excised, modiﬁed with acetic anhydride-
d6 (SIGMA) and digested with sequencing grade trypsin (Roche Diagnostics). The
peptides were extracted from gel, desalted on SCX and C/C18 home-made stage
tips39. Peptide mixtures were subjected to nUPLC-MS/MS analysis through the
Easy-nLC 1000 system coupled to Q-Exactive mass spectrometer (Thermo Fisher
Scientiﬁc), using a home-made 12.5 cm column (360 µm OD, 75 µm ID, 1.9 µm
Reprosil C18 AQ 120 Å resin, Dr Maisch GmbH), 0.1% formic acid in water as
solvent A and 0.1% formic acid in acetonitrile as solvent B. A gradient from 0 to
45% B in 45′ was applied in order to achieve peptide separation at 300 nl/min. Full
scan mass spectra were acquired on the Q-Exactive mass spectrometer in the mass
range m/z 300–2,000 Da with the resolution set to 70,000 at m/z 400 and a target
value (AGC) of 3 × 106. The ‘lock-mass’ option was used for accurate mass
measurements. The ten most intense doubly and triply charged ions were auto-
matically selected and fragmented by HCD with a normalized collision energy
setting of 27, AGC of 1 × 105 for MS/MS. Target ions already selected for the MS/
MS were dynamically excluded for 15 s. To quantify histone modiﬁcations, the area
under the curve (AUC) of the extracted ion chromatograms for the modiﬁed forms
relative to H3 peptides (and selectively relative to acetylated lysine 27 in H3(27–40)
peptide) was calculated using a mass tolerance of 10 p.p.m. and a mass precision up
to 4 decimals in the QualBrowser version 3.1.66.10. For each modiﬁed peptide, the
relative abundance percentage was evaluated as a ratio between the AUC of each
speciﬁc peptide over the sum of AUC of all the modiﬁed and unmodiﬁed forms of
the same peptide, applying the following formula:
Relative abundance %ð Þ ¼ XICmodified peptide
Σ XIC all observed isoforms
! "
´ 100:
Each modiﬁcation was validated by visual inspection of the mass spectra40.
Quantiﬁcation of lipid content. Quantiﬁcation of lipid content was performed
with Oil Red O (ORO) staining: staining was eluted from wells with 1.5 ml of 100%
isopropanol (10 min incubation) and absorbance was measured (500 nm, 0.5 s
reading). ORO staining quantiﬁcation was normalized for protein content.
Glycerol release. At the end of experiment, cell culture medium from C3H/10T1/
2 cells grown and differentiated in 12-well plates was collected. Glycerol release in
cell medium, as an index of FAs β-oxidation, was measured with Triglyceride
Dosage Kit (Sentinel) and normalized for protein content.
Gene expression. RNA from cell cultures was isolated with TRIzol (Invitrogen)
and puriﬁed using the Nucleospin RNA II kit (Macherey-Nagel). RNA from
adipose tissues was isolated with Qiazol and puriﬁed using Qiazol Reagent
(Qiagen), puriﬁed with commercial kit (RNeasy Lipid Tissue Mini kit, Qiagen), and
quantitated with Nanodrop (Thermo Scientiﬁc, Wilmington, DE). Speciﬁc mRNA
was ampliﬁed and quantitated by real time PCR, using iScriptTM One Step RT
PCR for Probes (cat. # 170-8894, Bio-Rad Laboratories), following the
manufacturer’s instructions. Data were normalized to 36B4 mRNA and quantitated
setting up a standard curve.
Samples were quantiﬁed by real-time PCR using SYBR Green or TaqMan
probes on a CFX384 real-time system instrument in 384 well format (Bio-Rad
Laboratories) using the iScriptTM one-step qRT-PCR kit for SYBR Green or for
probes (Bio-Rad Laboratories). Primers and probes were obtained from Euroﬁns
MWG Operon. For gene expression analysis in C3H/10T1/2 cells differentiated
with Scramble or shHdac3, data from four independent experiments were included
(n= 4). Complete list of primers is reported in Supplementary Table 3.
RNA-seq. RNA-seq was performed in triplicate. Each sequenced sample was a pool
of 500 ng of total RNA from IngWAT of 2/3 individual mice. RNA-seq libraries
were prepared with PolyA selection using 500 ng of total RNA and the Illumina
TruSeq Stranded RNA reagents (Illumina; San Diego, CA, USA) on a Sciclone
liquid handling robot (PerkinElmer; Waltham, MA, USA) using a PerkinElmer-
developed automated script. Cluster generation was performed with the resulting
libraries using the Illumina TruSeq SR Cluster Kit v3 reagents and sequenced on
the Illumina HiSeq 2500 using TruSeq SBS Kit v3 reagents. Sequencing data were
processed using the Illumina Pipeline Casava 1.82. Purity-ﬁltered reads were
adapter and quality trimmed with Cutadapt (v. 1.341, and ﬁltered for low
complexity with seq_crumbs (v. 0.1.8). Reads were aligned against Mus musculus
(version GRCm38) genome using STAR (v. 2.4.2a,42. The number of read counts
per gene locus was summarized with htseq-count (v. 0.6.1,43) using Mus musculus
(Ensembl v. GRCm38.82) gene annotation. Statistical analysis was performed for
genes in R (R version 3.2.3). Genes with low counts were ﬁltered out according to
the rule of 1 count per million (cpm) in at least 1 sample. Library sizes were scaled
using TMM normalization (EdgeR package version 3.12.144, and log-transformed
with limma voom function (Limma package version 3.26.9,45. Differential
expression was computed with limma46. We used DAVID47, 48 to highlight the
biological functions enriched in differentially expressed genes. The annotated terms
were grouped according to the degree of their co-association genes with the
functional annotation clustering feature (Supplementary Table 5). The Group
Enrichment Score, namely the geometric mean (in -log scale) of member’s p-values
in a corresponding annotation cluster, is used to rank their biological signiﬁcance.
Protein analysis. C3H/10T1/2 cells cultured in 6-well plate and adipose tissues
were lysed with SDS 2X sample buffer (20% glycerol, 4% SDS, 100 mM Tris-HCl
pH 6.8, 100 mM dithiothreitol, 0.002% bromophenol blue), 1 mM protease
inhibitors (Sigma), and homogenized with TissueLyser (Qiagen). Tissue lysates
were separated by SDS-PAGE and transferred onto nitrocellulose membranes, and
sample loading and transfer evaluated by Ponceau staining. Membranes were then
blocked in 5% non fat dry milk in 1× TBS. The primary antibodies are listed in
Supplementary Table 6.
HRP-conjugated goat anti-mouse (Sigma-Aldrich) and goat anti-rabbit
(Cell Signaling) secondary antibodies were used for detection with
chemiluminescence (ECL, Pierce).
Chromatin immunoprecipitation. IngWAT or C3H/10T1/2 cells infected with
100MOI scramble or shHDAC3 adenovectors and differentiated for 9 days were
cross-linked for 10 min with 1% formaldehyde. Cross-linking was stopped by
addition of glycine (ﬁnal concentration 125 mM). Cells were pelleted and lysed,
and DNA was sheared by sonication: 8–10 pulses for 10 s for 12 h-differentiated
cells and 15–20 pulses for 10 s for 9 days-differentiated cells (SLPe sonicator,
Branson). H3K27ac antibody (1 μg, ab4729, Abcam) was pre-incubated with 20 μl
G protein DynaBeads (Life technologies) for 1 h at room temperature, to allow the
binding of the antibody to Dynabeads. Cross-linked chromatin was incubated with
Dynabeads solution overnight at 4 °C. After reversing the crosslinking by
incubating overnight at 65 °C, the DNA was cleaned on QIAquick gel extraction kit
columns (QIAGEN). Inputs and immunoprecipitated samples were analyzed by
qRT-PCR using gene-speciﬁc primers, listed in Supplementary Table 4. Data are
expressed as 10% of input.
Animal studies. To obtain speciﬁc deletion of Hdac3 in adipose tissues, we crossed
Hdac3 ﬂoxed mice in C57Bl/6J background (provided by Dr. Scott Hiebert,
Vanderbilt University) with B6;FVB-Tg(Adipoq-cre) 1Evdr/J (stock # 010803, The
Jackson Laboratory).
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8-week-old male Hdac3 ﬂoxed and knock out mice were fed standard diet
(4RF21 GLP certiﬁcate, Mucedola), HFD (D12451, Research Diets), LFD
(D12450H) for 24 weeks monitoring body weight and fasting glycemia. At the end
of treatments, brown and white fat (inguinal subcutaneous and epididymal), liver
and blood samples were collected from individual animals. All the experiments
were performed on adult male mice (32 weeks old) in C57bl/6J background.
Triglyceride, NEFA and cholesterol levels were determined by Plasma
Triglyceride Kit (Sentinel), NEFA Kit (Wako Chemicals) and by Plasma
Cholesterol Kit (Sentinel). For glucose tolerance tests, mice were fasted for 16 h and
glucose levels from tail vein blood were determined before and 30, 60, 90, and 120,
150 and 180 min after i.p. injection of glucose (1 g/kg) using One touch Ultra
glucometer. For cold challenge test, basal rectal temperature was measured at 24 °C.
Then mice were housed at 4 °C and rectal temperature was measured every 20 min.
Of note, mice fed HFD were incubated at 4 °C up to 100 min because of
hypothermia; on the contrary, with mice fed LFD we were able to conduct the
cold challenge up to 24 h, measuring rectal temperature every hour. For collection
of BAT at 4 °C, mice at LF diet were housed to 4 °C for 24 h and BAT was
collected from individual animals at 4 °C.
All experiments were conducted following the regulations of the European
Community (EU Directive 86/609/CEE and 2010/63/EU of the European Union)
and local regulations (Italian Legislative Decree n. 116/1992 and n. 26/2014) for the
care and use of laboratory animals. The Italian Ministry of Health approved the
animal protocols of this study (protocols 06/2012 and898/2015-PR).
Histological analysis of adipose tissues. Brown adipose tissue, subcutaneous
WAT and liver were ﬁxed with Carnoy solution (6 parts 100% Ethanol, 3 parts
chloroform and 1 part glacial acetic acid) for 24 h at 4 °C. Tissues were then
transferred in 100% ethanol. Tissues were embedded in parafﬁn and 8 μm sections
were stained with hematoxylin and eosin. Images were taken at 20× magniﬁcation.
Cell size of adipocytes from WATs sections were quantiﬁed using the software
Photoshop CS6 (Adobe Systems Inc., San Jose, CA, USA).
Immunohistochemistry. Sections of WAT (8 µm) were deparafﬁnized, and anti-
gen retrieval was performed with 0.05 mol/l NH4Cl for 30 min, room temperature.
Endogenous peroxidase activity was blocked with 1% H2O2 for 20 min. Blocking
was performed in 1% BSA–0.1% Triton X-100 for 1 h. Anti-UCP1 (Abcam)
was applied (1:300) overnight at 4 °C. Incubation with biotinylated secondary
antibodies (1:3,000) followed. Histochemical reactions were performed using
diaminobenzidine.
Immunoﬂuorescence. Sections of subWAT (8 µm) were deparafﬁnized, and
antigen retrieval was performed with HCl 1N for 10 min at 4 °C and HCl 2N for
10 min, room temperature and 20 min at 37 °C. Blocking was performed in
5% BSA–0.1% Triton X-100 for 1 h. Anti-ACLY (Abcam) was applied (1:200)
overnight at 4 °C. Incubation with AlexaFluor 488 secondary antibodies (1:1,000)
followed. Nuclear staining was performed by adding Hoechst (1:1,000) for 30 min.
Nuclei containing green signal, as a measure of Acly localization in the
nucleus, were counted and divided by the total number of nuclei for each
section (n= 3 H3atKO mice vs. Floxed mice).
Mass spectrometry analysis. Inguinal and epididymal WAT from wild type and
H3atKO mice were homogenized in methanol with tissue lyser (Qiagen).
For the acylcarnitines and metabolites quantiﬁcation, methanolic extracts of
inguinal and epididymal WAT after addition of internal standard (O-Propionyl-L-
carnitine·HCl-D3, C3) were analyzed in the positive-ion mode by electrospray
ionization ﬂow injection analysis. For quantitative analysis of total FAs, methanolic
extracts of liver, subWAT and viscWAT, after addition of internal standards
(heneicosanoic acid, C21:0, and 13C-labeled linoleic acid, Sigma-Aldrich) were
subjected to acidic hydrolysis and processed as previously described49.
Acylcarnitine and FA quantiﬁcation were performed on an API-4000 triple
quadrupole mass spectrometer (AB SCIEX) coupled with a HPLC system (Agilent)
and CTC PAL HTS autosampler (PAL System). The quantiﬁcation of all
metabolites was normalized on protein content, as reported by Cummins and
collaborators50.
Statistical analyses. Statistical analyses were performed using the unpaired two-
tailed Student’s t-test, one way ANOVA or two way ANOVA, with Tukeys as
post hoc test, with GraphPad PRISM (San Diego, CA, USA).
Data availability. Gene expression data have been deposited in Gene Expression
Omnibus (GEO) under accession code GSE90987. The authors declare that all
data supporting the ﬁndings of this study are available within the article and
its Supplementary Information Files or from the corresponding author upon
reasonable request.
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